Robert J. Perez

Robert J. Perez (board member) discloses dealings in 6 companies, chiefly Cubist Pharmaceuticals Inc, AMAG Pharmaceuticals Inc. and Larimar Therapeutics, Inc. Between 3 January 2006 and 22 May 2023, the trades on record add up to 124 filings.

Both buying and selling appear: 1 purchase worth €74k, against 31 sales worth €11.7M. On balance, insiders were net sellers of €11.6M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 13 share grants and 37 option exercises.

Most recently, on 24 May 2023, the filings show a share grant in Vir Biotechnology, Inc. The last purchase on record was published on 21 April 2015, which is 4,203 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.